Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.
Dong, Yiyu
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. [electronic resource] - European urology focus 12 2017 - 590-598 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2405-4569
10.1016/j.euf.2016.08.005 doi
Aged
Animals
Antineoplastic Agents--pharmacology
Biopsy, Needle
Carcinoma, Renal Cell--drug therapy
Cell Line, Tumor
Feasibility Studies
Female
Heterografts
Humans
Kidney--pathology
Kidney Neoplasms--drug therapy
Male
Mice, Inbred NOD
Mice, SCID
Middle Aged
Random Allocation
Sunitinib--pharmacology
Transplantation, Heterologous
Treatment Outcome
Xenograft Model Antitumor Assays
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. [electronic resource] - European urology focus 12 2017 - 590-598 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2405-4569
10.1016/j.euf.2016.08.005 doi
Aged
Animals
Antineoplastic Agents--pharmacology
Biopsy, Needle
Carcinoma, Renal Cell--drug therapy
Cell Line, Tumor
Feasibility Studies
Female
Heterografts
Humans
Kidney--pathology
Kidney Neoplasms--drug therapy
Male
Mice, Inbred NOD
Mice, SCID
Middle Aged
Random Allocation
Sunitinib--pharmacology
Transplantation, Heterologous
Treatment Outcome
Xenograft Model Antitumor Assays